As of 2026-01-19, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 2.84 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.91 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -51.9%.
The range of the Relative Valuation is (0.18) - 6.45 CAD.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 22.1x | 6.3x |
| Forward P/E multiples | 49.1x - 64.1x | 58.8x |
| Fair Price | (0.18) - 6.45 | 2.84 |
| Upside | -103.0% - 9.1% | -51.9% |
| Date | P/E |
| 2026-01-15 | -169.70 |
| 2026-01-14 | -169.98 |
| 2026-01-13 | -167.99 |
| 2026-01-12 | -171.97 |
| 2026-01-09 | -169.98 |
| 2026-01-08 | -169.42 |
| 2026-01-07 | -171.12 |
| 2026-01-06 | -167.71 |
| 2026-01-05 | -166.57 |
| 2026-01-02 | -167.99 |
| 2025-12-31 | -171.97 |
| 2025-12-30 | -170.55 |
| 2025-12-29 | -170.55 |
| 2025-12-24 | -169.70 |
| 2025-12-23 | -169.98 |
| 2025-12-22 | -171.12 |
| 2025-12-19 | -170.55 |
| 2025-12-18 | -171.69 |
| 2025-12-17 | -171.41 |
| 2025-12-16 | -172.83 |
| 2025-12-15 | -170.84 |
| 2025-12-12 | -172.54 |
| 2025-12-11 | -172.83 |
| 2025-12-10 | -171.41 |
| 2025-12-09 | -168.28 |
| 2025-12-08 | -168.85 |
| 2025-12-05 | -171.97 |
| 2025-12-04 | -171.97 |
| 2025-12-03 | -171.69 |
| 2025-12-02 | -171.12 |
| 2025-12-01 | -172.26 |
| 2025-11-28 | -171.97 |
| 2025-11-27 | -172.54 |
| 2025-11-26 | -171.97 |
| 2025-11-25 | -171.12 |
| 2025-11-24 | -171.41 |
| 2025-11-21 | -173.96 |
| 2025-11-20 | -172.26 |
| 2025-11-19 | -174.25 |
| 2025-11-18 | -173.68 |
| 2025-11-17 | -174.25 |
| 2025-11-14 | -174.53 |
| 2025-11-13 | -174.82 |
| 2025-11-12 | -177.37 |
| 2025-11-11 | -177.09 |
| 2025-11-10 | -171.97 |
| 2025-11-07 | -171.97 |
| 2025-11-06 | -172.54 |
| 2025-11-05 | -166.00 |
| 2025-11-04 | -164.87 |